Technical Analysis for SPRB - Spruce Biosciences, Inc.

Grade Last Price % Change Price Change
F 0.49 0.89% 0.00
SPRB closed up 0.89 percent on Wednesday, November 20, 2024, on 40 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish 0.89%
NR7 Range Contraction 0.89%
Lower Bollinger Band Walk Weakness 0.89%
Lower Bollinger Band Touch Weakness 0.89%
Oversold Stochastic Weakness 0.89%
50 DMA Resistance Bearish 3.51%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 20 hours ago
Down 1% about 20 hours ago
50 DMA Resistance about 21 hours ago
Rose Above Previous Day's High about 22 hours ago
Rose Above 50 DMA about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Hyperplasia Endocrine Disorders Congenital Adrenal Hyperplasia Neurocrine Biosciences

Is SPRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.95
52 Week Low 0.4112
Average Volume 433,998
200-Day Moving Average 1.14
50-Day Moving Average 0.49
20-Day Moving Average 0.54
10-Day Moving Average 0.51
Average True Range 0.03
RSI (14) 43.50
ADX 23.63
+DI 13.63
-DI 20.62
Chandelier Exit (Long, 3 ATRs) 0.51
Chandelier Exit (Short, 3 ATRs) 0.57
Upper Bollinger Bands 0.60
Lower Bollinger Band 0.47
Percent B (%b) 0.16
BandWidth 24.69
MACD Line 0.00
MACD Signal Line 0.01
MACD Histogram -0.0099
Fundamentals Value
Market Cap 19.95 Million
Num Shares 40.7 Million
EPS -1.48
Price-to-Earnings (P/E) Ratio -0.33
Price-to-Sales 24.67
Price-to-Book 1.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.54
Resistance 3 (R3) 0.54 0.53 0.53
Resistance 2 (R2) 0.53 0.51 0.53 0.53
Resistance 1 (R1) 0.51 0.50 0.51 0.51 0.53
Pivot Point 0.49 0.49 0.49 0.49 0.49
Support 1 (S1) 0.47 0.48 0.47 0.47 0.45
Support 2 (S2) 0.46 0.47 0.46 0.45
Support 3 (S3) 0.44 0.46 0.45
Support 4 (S4) 0.44